Clinical trial

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

NCT01269710

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-10-01

PhaseN/A

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2013-02-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Psychotic Disorder, Not Otherwise Specifiedunresolved

Prodromal Schizophreniaunresolved

Mood Disorderunresolved

Bipolar Disorderunresolved

Major Depressive Disorderunresolved

Depressive Disorder, Not Otherwise Specifiedunresolved

Mood Disorder, Not Otherwise Specifiedunresolved

Autism Spectrum Disorderunresolved

Interventions

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01269710 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.